Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis

被引:0
|
作者
Peng, Fu-Sheng [1 ]
Wu, Wan-Ting [2 ]
Zhang, Lu [2 ]
Shen, Jia-Hua [3 ]
Yu, Dong-Dong [1 ]
Mao, Li-Qi [4 ]
机构
[1] Huzhou Univ, Dept Urol, Affiliated Cent Hosp, Huzhou Cent Hosp, Huzhou, Peoples R China
[2] Huzhou Univ, Major Clin Med, Huzhou, Peoples R China
[3] Huzhou Wu Xing Dist Med Insurance Management Serv, Dept Med Insurance Fund Supervis Sect, Huzhou, Peoples R China
[4] Huzhou Univ, Affiliated Hosp 1, Peoples Hosp Huzhou 1, Dept Gastroenterol, Huzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
cause of death; upper urinary tract carcinoma; standardized mortality ratios (SMRs); excess absolute risks (EARs); surveillance epidemiology and end results (SEER); TRANSITIONAL-CELL CARCINOMA; BLADDER-CANCER; SURVIVAL; URETER; PELVIS; RISK;
D O I
10.3389/fonc.2022.948289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundVery few studies have been published on the causes of death of upper tract urothelial carcinoma (UTUC). We sought to explore the mortality patterns of contemporary UTUC survivors. MethodsWe performed a retrospective cohort study involving patients with upper urinary tract carcinoma from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database (2000 and 2015). We used standardized mortality ratios (SMRs) to compare death rates among patients with UTUC in the general population and excess absolute risks (EARs) to quantify the disease-specific death burden. ResultsA total of 10,179 patients with UTUC, including 7,133 who died, were included in our study. In total, 302 (17.17%) patients with the localized disease died of UTUC; however, patients who died from other causes were 4.8 times more likely to die from UTUC (n = 1,457 [82.83%]). Cardiovascular disease was the most common non-cancer cause of death (n = 393 [22.34% of all deaths]); SMR, 1.22; 95% confidence intervals [CI], 1.1-1.35; EAR, 35.96). A total of 4,046 (69.99%) patients with regional stage died within their follow-up, 1,413 (34.92%) of whom died from UTUC and 1,082 (26.74%) of whom died from non-cancer causes. UTUC was the main cause of death (SMR, 242.48; 95% CI, 230-255.47; EAR, 542.47), followed by non-tumor causes (SMR, 1.18; 95% CI, 1.11-1.25; EAR, 63.74). Most patients (94.94%) with distant stage died within 3 years of initial diagnosis. Although UTUC was the leading cause of death (n = 721 [54.29%]), these patients also had a higher risk of death from non-cancer than the general population (SMR, 2.08; 95% CI, 1.67-2.56; EAR, 288.26). ConclusionsNon-UTUC deaths accounted for 82.48% of UTUC survivors among those with localized disease. Patients with regional/distant stages were most likely to die of UTUC; however, there is an increased risk of dying from non-cancer causes that cannot be ignored. These data provide the latest and most comprehensive assessment of the causes of death in patients with UTUC.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] A POPULATION-BASED COMPETING-RISKS ANALYSIS OF THE SURVIVAL OF PATIENTS TREATED WITH NEPHROURETERECTOMY (NU) FOR UPPER-TRACT UROTHELIAL CARCINOMA (UTUC)
    Sun, M.
    Thuret, R.
    Bhojani, N.
    Jeldres, C.
    Tian, Z.
    Ismail, S.
    Perrotte, P.
    Karakiewicz, P., I
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 118 - 118
  • [32] Trends in utilisation, perioperative outcomes, and costs of nephroureterectomies in the management of upper tract urothelial carcinoma: a 10-year population-based analysis
    Tinay, Ilker
    Gelpi-Hammerschmidt, Francisco
    Leow, Jeffrey J.
    Allard, Christopher B.
    Rodriguez, Dayron
    Wang, Ye
    Chung, Benjamin I.
    Chang, Steven L.
    BJU INTERNATIONAL, 2016, 117 (06) : 954 - 960
  • [33] Predictors of Upper Tract Urothelial Cell Carcinoma After Primary Bladder Cancer: A Population Based Analysis
    Wright, Jonathan L.
    Hotaling, James
    Porter, Michael P.
    JOURNAL OF UROLOGY, 2009, 181 (03): : 1035 - 1039
  • [34] Outcomes of radical nephroureterectomy for urothelial carcinoma: A contemporary series from the upper tract urothelial carcinoma collaboration
    Margulis, Vitaly
    Shariat, Shahrokh F.
    Matin, Surena F.
    Kamat, Ashish M.
    Lotan, Yair
    Koppie, Theresa M.
    Kikuchi, Eiji
    Mikami, Shuji
    Kosaka, Takeo
    Zigeuner, Richard
    Langner, Cord
    Bensalah, Karim
    Suardi, Nazareno
    Karakiewicz, Pierre I.
    Weizer, Alon Z.
    Raman, Jay D.
    Ng, Casey K.
    Fernandez, Mario
    Remzi, Mesut
    Haitel, Andrea
    Bolenz, Christian
    Strobel, Philipp
    Roscigno, Marco
    Montorsi, Francesco
    Wood, Christopher G.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 289 - 289
  • [35] A contemporary review of management and prognostic factors of upper tract urothelial carcinoma
    Leow, Jeffrey J.
    Orsola, Anna
    Chang, Steven L.
    Bellmunt, Joaquim
    CANCER TREATMENT REVIEWS, 2015, 41 (04) : 310 - 319
  • [36] Incidence and mortality of upper tract urothelial carcinoma in Korea: A nationwide population-based study conducted from 2002 to 2020
    Moon, Seongmin
    Ha, Yun-Sok
    Kim, Mina
    Kim, Hoseob
    Kim, Won Tae
    Kim, Yong-June
    Yun, Seok-Joong
    Lee, Sang-Cheol
    Kang, Ho Won
    INVESTIGATIVE AND CLINICAL UROLOGY, 2025, 66 (01) : 11 - 17
  • [37] Diagnostic pathways and treatment strategies in upper tract urothelial carcinoma in Sweden between 2015 and 2021: a population-based survey
    Liedberg, Fredrik
    Hagberg, Oskar
    Aljabery, Firas
    Gardmark, Truls
    Jahnson, Staffan
    Jerlstrom, Tomas
    Strock, Viveka
    Soderkvist, Karin
    Ullen, Anders
    Bobjer, Johannes
    SCANDINAVIAN JOURNAL OF UROLOGY, 2024, 59 : 19 - 25
  • [38] Marital status impacts survival in patients with upper tract urothelial carcinoma: a population-based, propensity-matched study
    Wang, Keyi
    Mao, Weipu
    Shi, Heng
    Wang, Guangchun
    Yin, Lei
    Xie, Jinbo
    Ian, Lap Hong
    Zhang, Hui
    Peng, Bo
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (04) : 1611 - 1629
  • [39] Impact of surgical management of upper tract urothelial cancer in octogenarians: A population-based study
    Wang, Shu
    Phelan, Michael
    Siddiqui, Mohummad Minhaj
    CURRENT UROLOGY, 2024, 18 (03) : 225 - 231
  • [40] TROUBLING OUTCOMES FROM A POPULATION LEVEL ANALYSIS OF SURGERY FOR UPPER TRACT UROTHELIAL CARCINOMA
    Abouassaly, Robert
    Alibhai, Shabbir M. H.
    Fleshner, Neil E.
    Timilshina, Narhari
    Finelli, Antonio
    JOURNAL OF UROLOGY, 2009, 181 (04): : 131 - 131